Prosthetic Graft Infection in Femoropopliteal Bypass

Authors

  • Maria Catarina-Ferreira Faculdade de Medicina da Universidade do Porto https://orcid.org/0009-0001-0614-1256
  • Lourenço Thierstein Faculdade de Medicina da Universidade do Porto; Serviço de Cirurgia - Unidade Local de Saúde de Santo António, Portugal https://orcid.org/0000-0001-8229-8215
  • António Pereira-Neves Department of Angiology and Vascular Surgery– Centro Hospitalar Universitário São João – Unidade Local de Saúde São João; Department of Biomedicine – Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Portugal https://orcid.org/0000-0003-0209-7670
  • João Rocha-Neves Department of Biomedicine – Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Portugal; CINTESIS@RISE, RISE-Health, Unit of Research, Porto, Portugal https://orcid.org/0000-0002-2656-8935
  • Leonardo Araújo-Andrade Department of Biomedicine – Unit of Anatomy, Faculdade de Medicina da Universidade do Porto, Portugal; Centro Hospitalar Universitário São João – Unidade Local de Saúde São João, Portugal https://orcid.org/0000-0002-3497-2743

DOI:

https://doi.org/10.48729/pjctvs.538

Keywords:

vascular graft infection, femoropopliteal bypass, prosthetic vascular graft, peripheral artery disease, postoperative complications

Abstract

Introduction: Peripheral artery disease, a manifestation of systemic atherosclerosis, often necessitates surgical revascularization in advanced stages, with femoropopliteal bypass serving as a primary intervention to restore adequate lower limb perfusion. When autologous vein grafts are not available, prosthetic conduits are commonly used. However, these heterologous materials carry an increased risk of infectious complications, which, although rare, are associated with substantial morbidity and mortality. This study aims to review the current literature on prosthetic graft infections in femoropopliteal bypass surgeries, focusing on epidemiology, risk factors, microbiology, diagnostic methods, treatment strategies, and preventive measures.
Materials and methods: A narrative review of the literature was conducted using databases such as PubMed to identify relevant studies on vascular prosthetic infections, particularly in femoropopliteal bypass surgeries.
Results: Prosthetic graft infections occur in approximately 2.6% of femoropopliteal bypass surgeries. Staphylococcus epidermidis is the most commonly isolated pathogen. Other relevant Gram-positive bacteria include Staphylococcus aureus, and Gram-negative bacteria such as Pseudomonas aeruginosa. Accurate identification of the etiological agent through microbiological and diagnostic methods is essential for improving clinical outcomes. Early diagnosis is crucial to enable timely and effective treatment, which generally combines antibiotic therapy with surgical intervention, often necessitating graft removal. Furthermore, adopting preventive measures, such as perioperative antibiotic prophylaxis, is fundamental to reducing the incidence of these complications and minimizing the morbidity and mortality associated with prosthetic graft infections.
Conclusion: Prosthetic graft infections in femoropopliteal bypass surgeries remain a challenging complication. A multidisciplinary approach encompassing early detection, evidence-based treatment, and targeted prevention strategies is essential to improve outcomes, preserve limb function, and mitigate long-term morbidity.

Downloads

Download data is not yet available.

References

Shamaki GR, Markson F, Soji-Ayoade D, Agwuegbo CC, Bampbose MO, Tamunohiemi BM. Peripheral Artery Disease: A Comprehensive Updated Review. Curr Probl Cardiol. 2022;47(11):101082.

Mandaglio-Collados D, Marin F, Rivera-Caravaca JM. Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment. Med Clin (Barc). 2023;161(8):344-50.

Criqui MH, Matsushita K, Aboyans V, Hess CM, Hicks CW, Kwan TW, et al. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021;144(9):e171-e91.

Verma S, Leiter LA, Mangla KK, Nielsen NF, Hansen Y, Bonaca MP. Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review. Diabetes Ther. 2024;15(9):1893-961.

Leroy O, Meybeck A, Sarraz-Bournet B, d'Elia P, Legout L. Vascular graft infections. Curr Opin Infect Dis. 2012;25(2):154-8.

Halena G, Krievins DK, Scheinert D, Savlovskis J, Szopinski P, Kramer A, et al. Percutaneous Femoropopliteal Bypass: 2-Year Results of the DETOUR System. J Endovasc Ther. 2022;29(1):84-95.

Ciaranella M, LoGerfo F, Liang P. Lower Extremity Bypass for Occlusive Disease: A Brief History. Ann Vasc Surg. 2024;107:17-30.

van de Weijer MA, Kruse RR, Schamp K, Zeebregts CJ, Reijnen MM. Morbidity of femoropopliteal bypass surgery. Semin Vasc Surg. 2015;28(2):112-21.

Madden NJ, Calligaro KD, Dougherty MJ, Zheng H, Troutman DA. Lateral femoral bypass for prosthetic arterial graft infections in the groin. J Vasc Surg. 2019;69(4):1129-36.

Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016;134(20):e412-e60.

Totty JP, Moss JWE, Barker E, Mealing SJ, Posnett JW, Chetter IC, et al. The impact of surgical site infection on hospitalisation, treatment costs, and health-related quality of life after vascular surgery. Int Wound J. 2021;18(3):261-8.

Gharamti A, Kanafani ZA. Vascular Graft Infections: An update. Infect Dis Clin North Am. 2018;32(4):789-809.

Chung J, Clagett GP. Neoacortoliac System (NAS) procedure for the treatment of the infected aortic graft. Semin Vasc Surg. 2011;24(4):220-6.

Young MH, Upchurch GR, Jr., Malani PN. Vascular graft infections. Infect Dis Clin North Am. 2012;26(1):41-56.

Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE, Jr., Bandyk DF. Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovascular Surg. 2011;45(8):688-96.

Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect. 2006;53(1):49-55.

Engin C, Posacioglu H, Ayik F, Apaydin AZ. Management of vascular infection in the groin. Tex Heart Inst J. 2005;32(4):529-34.

Kim Y, DeCarlo C, Jessula S, Latz CA, Chou EL, Patel SS, et al. Risk factors and consequences of graft infection after femoropopliteal bypass: A 25-year experience. J Vasc Surg. 2022;76(1):248-54.

Vriesendorp TM, Morelis QJ, Devries JH, Legemate DA, Hoekstra JB. Early post-operative glucose levels are an independent risk factor for infection after peripheral vascular surgery. A retrospective study. Eur J Vasc Endovasc Surg. 2004;28(5):520-5.

Groin wound infection after Vascular Exposure Study G. Groin wound infection after vascular exposure (GIVE) multicentre cohort study. Int Wound J. 2021;18(2):164-75.

Thomas S, Ghosh J, Porter J, Cockcroft A, Rautemaaakthandson R. Periodontal disease and late-onset aortic prosthetic vascular graft infection. Case Rep Vasc Med. 2015;2015:768935.

Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21(3):119-23.

Chelsea R, Astore D, Frigerio S, Garriboli L, Piccolo G, Castellano R, et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg. 2002;102(4):238-47.

O'Brien T, Collin J. Prosthetic vascular graft infection. Br J Surg. 1992;79(12):1262-7.

Chakfe N, Diener H, Lejay A, Assadian O, Berard X, Caillon J, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections. Eur J Vasc Endovasc Surg. 2020;59(3):339-84.

Laohapensang K, Arworn S, Orrapin S, Reanpang T, Orrapin S. Management of the infected aortic endograft. Semin Vasc Surg. 2017;30(2-3):91-4.

Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol. 2008;322:207-28.

Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett. 2004;230(1):13-8.

Erb S, Sidler JA, Elzi L, Gurke L, Battegay M, Widmer AF, et al. Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: a retrospective study of treatment outcomes. PLoS One. 2014;9(11):e112947.

Legout L, D'Elia PV, Sarraz-Bournet B, Haulon S, Meybeck A, Senneville E, et al. Diagnosis and management of prosthetic vascular graft infections. Med Mal Infect. 2012;42(3):102-9.

Siracuse JJ, Nandivada P, Giles KA, Hamdan AD, Myers MC, Chaikof EL, et al. Prosthetic graft infections involving the femoral artery. J Vasc Surg. 2013;57(3):700-5.

Geary KJ, Tomkiewicz ZM, Harrison HN, Fiore WM, Geary JE, Green RM, et al. Differential effects of a gram-negative and a gram-positive infection on autogenous and prosthetic grafts. J Vasc Surg. 1990;11(2):339-45; discussion 46-7.

Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55(4):733-51.

Foster TJ, Geoghegan JA, Ganesh VK, Hook M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12(1):49-62.

Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 1998;6(12):484-8.

Anderson O, Marian D, Olteanu G, Stancu B, Cucuruz B, Noppeney T. Complex treatment of vascular prostheses infections. Medicine (Baltimore). 2018;97(27):e11350.

Lyons OT, Bagunedi M, Barwick TD, Bell RE, Foster N, Homer-Vannissinkam S, et al. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52(6):758-63.

Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Callaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect. 2012;18(4):352-8.

Wouthuyzen-Bakker M, van Oosten M, Bierman W, Winter R, Glaudemans A, Slart R, et al. Diagnosis and treatment of vascular graft and endograft infections: a structured clinical approach. Int J Infect Dis. 2023;126:22-7.

Puges M, Pereyre S, Berard X, Accoceberry I, Le Roy C, Stecken L, et al. Comparison of Genus Specific PCR and Culture with or without Sonication for Microbiological Diagnosis of Vascular Graft Infection. Eur J Vasc Endovasc Surg. 2018;56(4):562-71.

Kokosar Ulcar B, Lakic N, Jeverica S, Pezavar B, Logar M, Cerar TK, et al. Contribution of sonicate-fluid cultures and broad-range PCR to microbiological diagnosis in vascular graft infections. Infect Dis (Lond). 2018;50(6):429-35.

Zhang Y, Feng S, Chen W, Zhang QC, Shi SF, Chen XY. Advantages of 16S rRNA PCR for the diagnosis of prosthetic joint infection. Exp Ther Med. 2020;20(4):3104-13.

Orton DF, Leveen RF, Saigh JA, Culp WC, Fidler JL, Lynch TJ, et al. Aortic prosthetic graft infections: radiological manifestations and implications for management. Radiographics. 2000;20(4):977-93.

Keidar Z, Pirmissabvili N, Leiderman M, Nitecki S, Israel O. 18F-FDG uptake in noninfected prosthetic vascular grafts: incidence, patterns, and changes over time. J Nucl Med. 2014;55(3):392-5.

Saleem BR, Pol RA, Slart RH, Reijnen MM, Zeebregts CJ. 18F-Fluorodeoxyglucose positron emission tomography/CT scanning in diagnosing vascular prosthetic graft infection. Biomed Res Int. 2014;2014:471971.

Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Pulppe G, et al. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg. 2015;49(4):455-64.

Anagnostopoulos A, Mayer F, Ledergerber B, Bergada-Pijuan J, Husmann L, Mestres CA, et al. Editor's Choice - Validation of the Management of Aortic Graft Infection Collaboration (MAGIC) Criteria for the Diagnosis of Vascular Graft/Endograft Infection: Results from the Prospective Vascular Graft Cohort Study. Eur J Vasc Endovasc Surg. 2021;62(2):251-7.

Haddad FS. Corrigenda. Bone Joint J. 2019;101-B(8):1032.

Saleem BR, Meerwaldt R, Tielilu IF, Verhoeven EL, van den Dungen JJ, Zeebregts CJ. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg. 2010;200(1):47-52.

Verma H, Kendis K, George RK, Tripathi R. Vacuum-assisted closure therapy for vascular graft infection (Szilagyi grade III) in the groin-a 10-year multi-center experience. Int Wound J. 2015;12(3):317-21.

Andersson S, Monsen C, Acosta S. Outcome and Complications Using Negative Pressure Wound Therapy in the Groin for Perivascular Surgical Site Infections after Vascular Surgery. Ann Vasc Surg. 2018;48:104-10.

Chatterjee A, Macarios D, Griffin L, Kosowski T, Pyfer BI, Offodile AC, 2nd, et al. Cost-Utility Analysis: Sartorius Flap versus Negative Pressure Therapy for Infected Vascular Groin Graft Management. Plast Reconstr Surg Glob Open. 2015;3(11):e566.

Thermann F, Wollett U. Continuous irrigation as a therapeutic option for graft infections of the groin. World J Surg. 2014;38(10):2589-96.

Ali AT, Modrall JG, Hocking J, Valentine RJ, Spencer H, Eidt JF, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg. 2009;50(1):30-9.

Coste A, Poinot M, Panaget S, Albert B, Kaladji A, Le Bars H, et al. Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infection. Infection. 2021;49(1):127-33.

Ehsan O, Gibbons CP. A 10-year experience of using femoro-popliteal vein for re-vascularisation in graft and arterial infections. Eur J Vasc Endovasc Surg. 2009;38(2):172-9.

Zetrenne E, McIntosh BC, McRae MH, Gusberg R, Evans GR, Narayan D. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J Biol Med. 2007;80(3):113-21.

Earnshaw JJ. The current role of rifampicin-impregnated grafts: pragmatism versus science. Eur J Vasc Endovasc Surg. 2000;20(5):409-12.

Berard X, Stecken L, Phraquy JB, Cazanaev C, Puges M, Pereyre S, et al. Comparison of the Antimicrobial Properties of Silver Impregnated Vascular Grafts with and without Triclosan. Eur J Vasc Endovasc Surg. 2016;51(2):285-92.

Minga Lowampa E, Holemans C, Stiennon L, Van Damme H, Defraigne JO. Late Fate of Cryopreserved Arterial Allografts. Eur J Vasc Endovasc Surg. 2016;52(5):696-702.

Lejay A, Delay C, Girsowicz E, Chenesseau B, Bonnin E, Ghariani MZ, et al. Cryopreserved Cadaveric Arterial Allograft for Arterial Reconstruction in Patients with Prosthetic Infection. Eur J Vasc Endovasc Surg. 2017;54(5):636-44.

McCready RA, Bryant MA, Fehrenbacher JW, Beckman DJ, Coffey AC, Corvera JS, et al. Long-term results with cryopreserved arterial allografts (CPAs) in the treatment of graft or primary arterial infections. J Surg Res. 2011;168(1):e149-53.

McMillan WD, Leville CD, Hile CN. Bovine pericardial patch repair in infected fields. J Vasc Surg. 2012;55(6):1712-5.

Brewer MB, Ochoa CJ, Woo K, Wartman SM, Nikolian V, Han S, et al. Sartorius Muscle Flaps for Vascular Groin Wound Complications. Am Surg. 2015;81(11):1163-9.

Fischer JP, Mirzabeigi MN, Sieber BA, Nelson JA, Wu LC, Kovach SJ, et al. Outcome analysis of 244 consecutive flaps for managing complex groin wounds. J Plast Reconstr Aesthet Surg. 2013;66(10):1396-404.

Ali AT, Rueda M, Desikan S, Moussi MM, An R, Spencer H, et al. Outcomes after retroflexed gracilis muscle flap for vascular infections in the groin. J Vasc Surg. 2016;64(2):452-7.

Stone PA, Mousa AY, Hass SM, Dearing DD, Campbell JR, 2nd, Parker A, et al. Antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary vascular surgical site infections. J Vasc Surg. 2012;55(6):1706-11.

Pol MJ, Pismisis G, Barshes NR, Darouiche RO, Lin PH, Kougias P, et al. Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections. Surgery. 2013;153(5):673-82.

Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422-9.

Revest M, Camou F, Senneville E, Caillon J, Laurent F, Calvet B, et al. Medical treatment of prosthetic vascular graft infections: Review of the literature and proposals of a Working Group. Int J Antimicrob Agents. 2015;46(3):254-65.

Hodgkiss-Harlow KD, Bandyk DF. Antibiotic therapy of aortic graft infection: treatment and prevention recommendations. Semin Vasc Surg. 2011;24(4):191-8.

Kaiiberg A, Melissano G, Mascia D, Loschi D, Grandi A, Chiesa R. How to best treat infectious complications of open and endovascular thoracic aortic repairs. Semin Vasc Surg. 2017;30(2-3):95-102.

Ambler GK, Twine CP. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev. 2018;2(2):CD001487.

Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37(1):149-55.

Ricco JB, InterGard Silver Study G. InterGard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg. 2006;44(2):339-46.

Rocha-Neves J, Ferreira A, Sousa J, Pereira-Neves A, Vidoedo J, Alves H, et al. Endovascular Approach Versus Aortobifenoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease. Vasc Endovascular Surg. 2020;54(2):102-10.

Zdanowski Z, Ribbe E, Schalen C. Influence of some plasma proteins on in vitro bacterial adherence to PTFE and Dacron vascular prostheses. APMIS. 1993;101(12):926-32.

Chen L, He H, Wang M, Li X, Yin H. Surface Coating of Polytetrafluoroethylene with Extracellular Matrix and Anti-CD34 Antibodies Facilitates Endothelialization and Inhibits Platelet Adhesion Under Sheer Stress. Tissue Eng Regen Med. 2017;14(4):359-70.

Naito Y, Shinoka T, Duncan D, Hibino N, Solomon D, Cleary M, et al. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011;63(4-5):312-23.

Costa Almeida CE, Reis L, Carvalho L, Costa Almeida CM. Collagen implant with gentamicin sulphate reduces surgical site infection in vascular surgery: a prospective cohort study. Int J Surg. 2014;12(10):1100-4.

Langenberg JCM, Kluytmans J, Mulder PGH, Romme J, Ho GH, Van Der Laan L. Peri-Operative Nasal Eradication Therapy Prevents Staphylococcus aureus Surgical Site Infections in Aortoiliac Surgery. Surg Infect (Larchmt). 2018;19(5):510-5.

Stewart AH, Eyers PS, Earnshaw JJ. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg. 2007;46(1):148-55.

van der Siegt J, van der Laan L, Veen EJ, Hendriks Y, Romme J, Kluytmans J. Implementation of a bundle of care to reduce surgical site infections in patients undergoing vascular surgery. PLoS One. 2013;8(8):e71566.

Parizh D, Ascher E, Raza Rizvi SA, Hingorani A, Amaturo M, Johnson E. Quality improvement initiative: Preventative Surgical Site Infection Protocol in Vascular Surgery. Vascular. 2018;26(1):47-53.

Matatov T, Reddy KN, Doucet LD, Zhao CX, Zhang WW. Experience with a new negative pressure incision management system in prevention of groin wound infection in vascular surgery patients. J Vasc Surg. 2013;57(3):791-5.

Downloads

Published

04-08-2025

How to Cite

1.
Catarina-Ferreira M, Thierstein L, Pereira-Neves A, Rocha-Neves J, Araújo-Andrade L. Prosthetic Graft Infection in Femoropopliteal Bypass. Rev Port Cir Cardiotorac Vasc [Internet]. 2025 Aug. 4 [cited 2025 Sep. 5];32(2):59-68. Available from: https://pjctvs.com/index.php/journal/article/view/538

Issue

Section

Review Article

Categories

Most read articles by the same author(s)

1 2 > >>